Normal view MARC view ISBD view

HLA-DR typing of renal allograft patients and donors by DNA-RFLP: correlation with pretransplant serotyping. [electronic resource]

By:

Wood, N

Contributor(s):

Producer: 19901121Description: 2287 p. digitalISSN:

0041-1345

Subject(s):

In: Transplantation proceedings vol. 22

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Clinical Trial; Comparative Study; Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas.
by Bota, Daniela A
2 A practical approach to hyperglycemia management in the intensive care unit: evaluation of an intensive insulin infusion protocol.
by Quinn, Jennifer A
3 Molecularly targeted therapy for malignant glioma.
by Sathornsumetee, Sith
4 Connexin31-deficient trophoblast stem cells: a model to analyze the role of gap junction communication in mouse placental development.
by Kibschull, Mark
5 Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
by Korones, David N
6 O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma.
by Jiang, Xiaoyin
7 Chemotherapy and novel therapeutic approaches in malignant glioma.
by Desjardins, Annick
8 Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.
by Reardon, David A
9 Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
by Quinn, Jennifer A
10 Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
by Quinn, Jennifer A
11 Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma.
by Maxwell, Jill A
12 Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft.
by Cheng, C Lynn
13 Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme.
by Badruddoja, Michael A
14 Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.
by Vredenburgh, James J
15 Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.
by Gururangan, Sridharan
16 Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.
by Maxwell, Jill A
17 Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.
by Desjardins, Annick
18 Temozolomide in children with progressive low-grade glioma.
by Gururangan, Sridharan
19 Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.
by Reardon, David A
20 Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.
by Vredenburgh, James J